Danger Is Lurking

High blood pressure is a silent killer.


For people with high blood pressure, reducing your systolic blood pressure by even 2-5 mm Hg may lower your risk of coronary- and stroke-related death.a

Learn about Edarbi®
(azilsartan medoxomil)Learn about Edabyclor®
(azilsartan medoxomil/chlorthalidone)
Abbreviation: mm Hg=millimeters of mercury.
aCardiovascular risk reduction with Edarbi and Edarbyclor has not been established.

Danger Is Lurking

High blood pressure is a silent killer.


For people with high blood pressure, reducing your systolic blood pressure by even 2-5 mm Hg may lower your risk of coronary- and stroke-related death.a

Learn about Edarbi®
(azilsartan medoxomil)Learn about Edabyclor®
(azilsartan medoxomil/chlorthalidone)
Abbreviation: mm Hg=millimeters of mercury.
aCardiovascular risk reduction with Edarbi and Edarbyclor has not been established.

High blood pressure is a silent killer

  • In 2022, high blood pressure was a primary or contributing cause of ~686,000 deaths in the United States.

If you have high blood pressure, you are not alone

  • As of 2020, it was estimated that 119.9 million adults in the United States have high blood pressure. That’s 48% of the adult population.
  • That means more Americans than ever before are living with this condition. Edarbi and Edarbyclor are powerful choices for you and your doctor to consider.


Take Control With
a Powerful ARB

Edarbi is an ARB that may reduce your blood pressure. Clinical studies have shown Edarbi is more effective in lowering blood pressure than Benicar® (olmesartan medoxomil) or Diovan® (valsartan).

Learn About Edarbi


Take Control With a
Powerful ARB + Water Pill (Diuretic)

If a single medication hasn't helped lower your blood pressure, Edarbyclor may be the answer. Edarbyclor was shown to be more effective in lowering blood pressure than Benicar HCT® (olmesartan medoxomil-hydrochlorothiazide) in a clinical study.

Learn About Edarbi
Abbreviation:  ARB=angiotensin II receptor blocker.
Learn About Edarbyclor
Abbreviation:  ARB=angiotensin II receptor blocker.

Learn More About High Blood Pressure

And What You Can Do to Take Control

Millions of people just like you are monitoring and managing their blood pressure every day. Learn about causes, risks, guidelines, and more—and find a guide to taking your own blood pressure.

Start Learning Now

Save on Edarbi and Edarbyclor, Whatever Your Insurance Coverage

No matter what your current insurance coverage is, we have programs that may help you get the prescription treatment you need at a cost you can afford. Even if you're between insurance or underinsured right now, we have programs to help you get access to the prescriptions you need.

See Savings Programs

IMPORTANT SAFETY INFORMATION

Plus Icon

INDICATIONS

EDARBI® is a prescription medicine used to treat high blood pressure (hypertension) in adults and EDARBYCLOR® is a prescription medicine used to treat high blood pressure (hypertension). Your doctor may prescribe other medicines for you to take along with EDARBI or EDARBYCLOR to treat your high blood pressure. EDARBYCLOR is used when one medicine is not enough or as the first medicine if your doctor decides you are likely to need more than one medicine. Medicines that lower your blood pressure may lower your chances of having a stroke or heart attack, but they don't work alone. They should be part of a complete treatment plan.

WARNING: FETAL TOXICITY

See full prescribing information for complete boxed warning

  • When pregnancy is detected, discontinue EDARBI or EDARBYCLOR as soon as possible
  • Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus
  • Before taking EDARBI or EDARBYCLOR, tell your doctor if you are breastfeeding or plan to breastfeed. Discuss with your doctor other ways to lower your blood pressure. Breastfeeding while taking EDARBI or EDARBYCLOR is not recommended.
  • Do not take EDARBYCLOR if you make less urine because of kidney problems (anuria).
  • Do not take aliskiren-containing products with EDARBI or EDARBYCLOR if you have diabetes.
  • Tell your doctor about all your medical conditions, including if you have heart problems or stroke, have gout, or have liver or kidney problems. Kidney problems may become worse in people that already have kidney disease. If you have kidney problems, you may need blood tests, and your doctor may need to lower your dose or may need to stop treatment with EDARBYCLOR. During treatment with EDARBI or EDARBYCLOR, certain people who have severe heart failure, narrowing of the artery to the kidney, or who lose too much body fluid such as with nausea, vomiting, bleeding, or trauma, may develop sudden kidney failure and in rare instances, death.
  • Tell your doctor about all the medicines you take, including prescription and nonprescription medicines, vitamins, and herbal supplements. Especially tell your doctor if you take other medicines to treat your high blood pressure or heart problem; water pills (diuretics); lithium; or digoxin.
  • EDARBI and EDARBYCLOR may cause serious side effects, including low blood pressure (hypotension) which may cause you to feel faint or dizzy. Vomiting and diarrhea, a low salt diet, sweating a lot, or not drinking enough fluid can also lead to low blood pressure.
  • If you feel faint or dizzy, lie down and call your doctor right away. If you pass out (faint), have someone call your doctor or get medical help. Stop taking EDARBYCLOR.
  • If you have fluid and body salt (electrolyte) problems, tell your doctor if you experience any of the following symptoms: dry mouth, confusion, thirst, lack of energy (lethargic), weakness, drowsiness, passing very little urine or passing large amounts of urine, seizures, muscle pain/cramps, restlessness, muscle tiredness (fatigue), fast or abnormal heartbeat, nausea and vomiting, or constipation.
  • People who have increased levels of uric acid in the blood may develop gout. If you already have gout, tell your doctor about worsening of your gout symptoms.
  • In clinical studies, the most common side effect seen with EDARBI was diarrhea (2.0%).
  • In a clinical study, the side effects seen with EDARBYCLOR included dizziness (8.9%) and tiredness (2.0%).

The Important Safety Information does not include all the information needed to use EDARBI and EDARBYCLOR safely and effectively.

For further information, please see accompanying complete Prescribing Information for EDARBI and EDARBYLCOR.

To report SUSPECTED ADVERSE REACTIONS, contact Azurity Pharmaceuticals, Inc. at 1-800-461-7449 or to the FDA at www.fda.gov/medwatch or call 1-800-FDA-1088.

PP-EDB-US-0744